Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. The DIGITS Trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, and Kaiser Permanente Washington, a healthcare delivery system in Washington State.
In this study, the FDA-authorized reSET and reSET-O digital therapeutics will be implemented in Kaiser Permanente Washington primary care clinics. The study will evaluate the extent to which two implementation strategy interventions, health coaching and practice coaching, improve the implementation. Primary care clinics are randomized to receive these implementation strategy interventions. Each clinic will have a 12-month active implementation period beginning on its date of randomization. To study the continued use of reSET and reSET-O after the active implementation period is completed, a sustainment period of up 12 months will follow the active implementation period.
Full description
Specific Aims of the DIGITS Trial are to:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Patient Inclusion Criteria:
Clinic Inclusion Criteria:
Patient Exclusion Criteria:
Clinic Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
13,000 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal